Top Markets
Coin of the day
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
주식 순위 #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
주가
$0.069
마지막 동기화: 2024-07-22
시가총액
$2.06M
변동 (1일)
-1.43%
변동 (1년)
0.00%
국가
US
거래 DermTech, Inc. (DMTK)

카테고리

DermTech, Inc. (DMTK)의 발행 주식 수
March 2024 기준 발행 주식 수: 34.71M
DermTech, Inc.의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 34.71M입니다. December 2022 말 기준 회사는 30.04M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
DermTech, Inc. (DMTK)의 발행 주식 수 기록 (2012 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 34.71M 6.33%
2023 32.64M 8.66%
2022 30.04M 4.00%
2021 28.89M 70.12%
2020 16.98M 142.38%
2019 7.01M 196.70%
2018 2.36M 29.52%
2017 1.82M -61.36%
2013 4.72M 37.11%
2012 3.44M 0.00%
유사 기업 또는 경쟁사의 발행 주식 수
회사 발행 주식 수 차이 국가
371.00M 968.98%
US
705.30M 1,932.21%
US
- -
CN
143.28M 312.84%
US
80.10M 130.78%
US